000 01343 a2200349 4500
005 20250517093726.0
264 0 _c20170731
008 201707s 0 0 eng d
022 _a1749-6632
024 7 _a10.1111/nyas.13053
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChambers, Janice E
245 0 0 _aNovel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_c06 2016
300 _a52-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aBrain
_xdrug effects
650 0 4 _aCholinesterase Inhibitors
_xpharmacology
650 0 4 _aCholinesterases
_xmetabolism
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aOrganothiophosphorus Compounds
_xtoxicity
650 0 4 _aOximes
_xchemistry
650 0 4 _aRats
650 0 4 _aSarin
_xtoxicity
650 0 4 _aSurvival Analysis
700 1 _aMeek, Edward C
700 1 _aChambers, Howard W
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 1374
_gno. 1
_gp. 52-8
856 4 0 _uhttps://doi.org/10.1111/nyas.13053
_zAvailable from publisher's website
999 _c25995620
_d25995620